Transforming growth factor-β-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression

被引:14
作者
Diener, Kerrilyn R. [1 ,2 ]
Woods, Anthony E. [1 ]
Manavis, Jim [3 ,4 ]
Brown, Michael P. [2 ,5 ,6 ]
Hayball, John D. [1 ,2 ,6 ]
机构
[1] Univ S Australia, Sansom Inst, Adelaide, SA 5000, Australia
[2] Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia
[3] Hanson Inst, Ctr Neurol Dis, Adelaide, SA, Australia
[4] SA Pathol, Dept Neuropathol, Adelaide, SA, Australia
[5] Royal Adelaide Hosp, Dept Med Oncol, Adelaide, SA 5000, Australia
[6] Univ Adelaide, Sch Med, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
adoptive transfer; OT-I T cells; CD4-dnTGFRII; prostate cancer; TRANSGENIC MOUSE; DENDRITIC CELLS; SIPULEUCEL-T; CANCER CELLS; II RECEPTOR; EXPRESSION; RESPONSES; MICE; FACTOR-BETA-1; BLOCKADE;
D O I
10.1038/labinvest.2008.123
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
T cells are in general tolerant of prostate-specific tumor antigens. That prostate tumor tissue makes transforming growth factor-beta (TGF beta) is thought to play a role in the induction of T-cell tolerance within the host and to contribute to tumor progression itself. Here we sought to investigate the influence of TGF beta signaling on prostate antigen-specific T-cell responses as well as prostate tumorogenesis in an autochthonous murine model of the disease. The response of naive and activated ovalbumin ( OVA) antigen-specific T cells, which had been rendered incapable of responding to TGF beta through T-cell-specific transgenic expression of a dominant-negative variant of the TGF beta receptor II (dnTGFRII), was analyzed after adoptive transfer into prostate OVA-expressing transgenic ( POET) mice. The role of TGFb beta signaling in endogenous T cells in mice, which spontaneously form tumors, was also assessed by monitoring prostate tumor formation and progression in F1 progeny of productive matings between transgenic adenocarcinoma of the mouse prostate ( TRAMP) and dnTGFRII mice. TGF beta-resistant CD8(+) T cells proliferated more and produced IFN gamma more readily after OVA stimulation in vitro. OVA-specific T cells did not damage the prostate gland of POET mice irrespective of TGF beta responsiveness. However, ex vivo activation facilitated entry of TGF beta-insensitive T cells into the prostate and was associated with prostate tissue damage. Early tumor progression was delayed in TRAMP mice that carried endogenous TGF beta-insensitive T cells. Together, these results suggest that TGF beta-signaling represses CD8(+) T-cell responses to a prostate-specific antigen. TGF beta-mediated repression of T-cell function may include production of IFN gamma which is known to contribute to tumor immunosurveillance. Laboratory Investigation ( 2009) 89, 142-151; doi: 10.1038/labinvest.2008.123; published online 15 December 2008
引用
收藏
页码:142 / 151
页数:10
相关论文
共 48 条
[1]
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression [J].
Ahmad, M ;
Rees, RC ;
Ali, SA .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (10) :844-854
[2]
Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer [J].
Anderson, Michael J. ;
Shafer-Weaver, Kimberly ;
Greenberg, Norman M. ;
Hurwitz, Arthur A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1268-1276
[3]
Advances in prostate cancer immunotherapies [J].
Basler, Michael ;
Groettrup, Marcus .
DRUGS & AGING, 2007, 24 (03) :197-221
[4]
Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P1
[5]
Danielpour D, 1999, J CELL SCI, V112, P169
[6]
Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization [J].
Degl'Innocenti, E ;
Grioni, M ;
Boni, A ;
Camporeale, A ;
Bertilaccio, MTS ;
Freschi, M ;
Monno, A ;
Arcelloni, C ;
Greenberg, NM ;
Bellone, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) :66-75
[7]
TGF-BETA-RECEPTOR-MEDIATED SIGNALING [J].
DERYNCK, R .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (12) :548-553
[8]
Human Flt-3 ligand-mobilized dendritic cells, require additional activation to drive effective immune responses [J].
Diener, Kerrilyn R. ;
Moldenhauer, Lachlan M. ;
Lyons, A. Bruce ;
Brown, Michael P. ;
Hayball, John D. .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (01) :51-60
[9]
Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[10]
Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296